We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies on the site. Please see our Privacy Policy for details.

Stephen Bernstein was quoted in the January 29 iss

January 29, 2009

In Depth

Stephen Bernstein was quoted in the January 29 issue of FDA Webview in an article regarding a New Hampshire law that violates the Firm Amendment because it prohibits the transfer of prescriber-identifiable information for use by drug companies field representations. "If the transfer of the information was the target of the conduct restraint, then, at a minimum, all the information transfers for all commercial uses would have been forbidden, instead of just those having to do with the ensuing commercial use in influencing physician behavior," Mr. Bernstein said.